MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-12-2023
PolarityTE Depreciation & Amortization 2011-2026 | PTE
Annual Depreciation & Amortization PolarityTE
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.51 M | 2.65 M | 3.07 M | 2.99 M | 1.39 M | 432 K | 27 K | 61 K | 745 K | 381 K | 566 K | 398 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.07 M | 27 K | 1.19 M |
Quarterly Depreciation & Amortization PolarityTE
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 148 K | - | 373 K | 403 K | 455 K | - | 646 K | 736 K | 701 K | - | 788 K | 797 K | 752 K | - | 797 K | 770 K | 676 K | 330 K | 1.09 M | 672 K | 318 K | 83 K | 295 K | 173 K | 101 K | 7 K | - | 7 K | 7 K | 40 K | 57 K | 7 K | 7 K | 81 K | 304 K | 117 K | 106 K | 111 K | 296 K | 90 K | 95 K | 158 K | 448 K | 141 K | 149 K | 45 K | 223 K | 121 K | 57 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.09 M | 7 K | 313 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M |  USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Compugen Ltd.
CGEN
|
461 K | $ 2.59 | -5.31 % | $ 242 M |  Israel |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 0.91 | 3.25 % | $ 6.69 M | China |
 |
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.57 | -0.44 % | $ 3.74 B | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
487 K | - | 17.91 % | $ 11.1 M | USA |
 |
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
199 K | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | USA |
 |
Innoviva
INVA
|
26.3 M | $ 23.2 | -2.08 % | $ 1.56 B | USA |
 |
Aquestive Therapeutics
AQST
|
548 K | $ 4.06 | -0.73 % | $ 434 M | USA |
 |
Jaguar Health
JAGX
|
1.91 M | $ 0.23 | -5.44 % | $ 536 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
700 K | $ 22.63 | -2.86 % | $ 2.88 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
969 K | $ 26.73 | 38.9 % | $ 1.44 B |  Britain |
 |
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.42 | -4.39 % | $ 378 M | Britain |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 2.95 | 1.37 % | $ 4.86 M | Israel |